C6orf226 Antibody Blocking peptide
C6orf226 Antibody Blocking peptide
Product Specifications
Product Name Alternative
Uncharacterized protein C6orf226, C6orf226
UniProt
Q5I0X4
Form
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Notes
For research use only.
Applications Notes
Synthetic peptide
AA Sequence
The synthetic peptide sequence was selected from the Center region of C6orf226. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-EP3325GMY-01 100 µg
Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (Active)
Sign In for Pricing
View Details CSB-EP3325GMY-02 1 mg
Recombinant Severe acute respiratory syndrome coronavirus 2 Nucleoprotein (N) (Active)
Sign In for Pricing
View Details 
MBS6236633-01 0.1 mL
BCL10 (B Cell CLL/lymphoma 10, B Cell Leukemia/lymphoma 10, CARD-containing Molecule enhancing NF-kappa-B, CARD-like apoptotic Protein, caspase-recruiting domain-containing Protein, CED-3/ICH-1 Prodomain Homologous E10-like Regulator, Cellular Homolog of
Sign In for Pricing
View Details MBS6236633-02 5x 0.1 mL
BCL10 (B Cell CLL/lymphoma 10, B Cell Leukemia/lymphoma 10, CARD-containing Molecule enhancing NF-kappa-B, CARD-like apoptotic Protein, caspase-recruiting domain-containing Protein, CED-3/ICH-1 Prodomain Homologous E10-like Regulator, Cellular Homolog of
Sign In for Pricing
View Details